CytoDyn Inc. Contracts & Agreements

Consulting Agreement between the Company and Rapid Deployment LLC (Filed With SEC on April 15, 2024)

Description of the Registrants Capital Stock (Filed With SEC on February 7, 2024)

Employment Agreement between the Company and Jacob P. Lalezari, M.D., dated January 26, 2024 (Filed With SEC on January 29, 2024)

Employment Agreement between the Company and Jacob P. Lalezari, M.D., dated November 17, 2023 (Filed With SEC on November 21, 2023)

Employment Agreement between CytoDyn Inc. and Tyler Blok, effective August 15, 2023 (Filed With SEC on October 23, 2023)

Description of the Registrants Capital Stock (Filed With SEC on September 14, 2023)

Initial Warrant Issued under Surety Bond Backstop Extension (Filed With SEC on September 14, 2023)

Subsequent Warrant Issued under Surety Bond Backstop Extension (Filed With SEC on September 14, 2023)

Form Stock Option Award Agreement (For Non-Employee Directors) (Filed With SEC on January 9, 2023)

Form Stock Option Award Agreement (For Executives) (Filed With SEC on January 9, 2023)

Amended and Restated 2012 Equity Incentive Plan (Filed With SEC on January 9, 2023)

Second Amendment dated December 1, 2022, to Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on December 7, 2022)

Description of the Registrants Capital Stock (Filed With SEC on August 15, 2022)

Warrant Issued to Richard G. Pestell (Filed With SEC on August 15, 2022)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Biomm S.A., dated April 6, 2021 (Filed With SEC on August 15, 2022)

CERTAIN IDENTIFIED INFORMATION MARKED BY [*] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT... (Filed With SEC on August 15, 2022)

Employment Agreement between CytoDyn Inc. and Cyrus Arman, effective July 9, 2022 (Filed With SEC on August 15, 2022)

Settlement Agreement dated May 19, 2022, between CytoDyn Inc. and Richard G. Pestell, M.D., Ph.D (Filed With SEC on August 15, 2022)

Amendment dated July 18, 2022, to Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on July 25, 2022)

Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (Filed With SEC on April 11, 2022)

Separation Agreement and Release of Claims Claims with Nader Z. Pourhassan, Ph.D., effective March 8, 2022 (Filed With SEC on April 11, 2022)

Form of Initial Warrant (Filed With SEC on February 17, 2022)

Form of Make-Whole Warrant (Filed With SEC on February 17, 2022)

Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (the Company agrees to furnish a copy of Schedule 3, which has been... (Filed With SEC on February 17, 2022)

Form of Subscription Agreement (Filed With SEC on November 23, 2021)

Employment Agreement by and between CytoDyn Inc. and Antonio Migliarese, effective May 18, 2021 (Filed With SEC on October 12, 2021)

Form of Warrant (Filed With SEC on September 7, 2021)

Form of Subscription Agreement (Filed With SEC on September 7, 2021)

Form of Warrant Exercise Inducement Agreement (Filed With SEC on September 7, 2021)

Description of the Registrants Capital Stock (Filed With SEC on July 30, 2021)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Biomm S.A., dated April 6, 2021 (Filed With SEC on July 30, 2021)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Chiral Pharma Corporation (Filed With SEC on July 30, 2021)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Chiral Pharma Corporation, as amended by Amendment No. 1, dated April 19, 2021 (Filed With SEC on July 30, 2021)

Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Macleods Pharmaceuticals Ltd., dated May 11, 2021 (Filed With SEC on July 30, 2021)

Separation Agreement and Release of Claims between CytoDyn Inc. and Mahboob U. Rahman, M.D., Ph.D., dated June 1, 2021 (Filed With SEC on July 30, 2021)

Secured Convertible Promissory Note dated April 23, 2021 (Filed With SEC on April 29, 2021)

Securities Purchase Agreement between CytoDyn Inc. and Uptown Capital, LLC dated April 23, 2021 (Filed With SEC on April 29, 2021)

Security Agreement between CytoDyn Inc. and Uptown Capital, LLC dated April 23, 2021 (Filed With SEC on April 29, 2021)

Employment Agreement by and between CytoDyn Inc. and Christopher P. Recknor, M.D., dated March 11, 2021 (Filed With SEC on April 14, 2021)

Secured Convertible Promissory Note dated April 2, 2021 (Filed With SEC on April 8, 2021)

Securities Purchase Agreement between CytoDyn Inc. and Streeterville Capital LLC dated April 2, 2021 (Filed With SEC on April 8, 2021)

Security Agreement between CytoDyn Inc. and Streeterville Capital LLC dated April 2, 2021 (Filed With SEC on April 8, 2021)

Form of Warrant Exercise Inducement Agreement (Filed With SEC on January 29, 2021)

Employment Agreement by and between CytoDyn Inc. and Mahboob Rahman M.D., Ph.D., dated October 16, 2020 (Filed With SEC on January 8, 2021)

Secured Convertible Promissory Note dated November 10, 2020 (Filed With SEC on November 16, 2020)

Securities Purchase Agreement between CytoDyn Inc. and Streeterville Capital, LLC dated November 10, 2020 (Filed With SEC on November 16, 2020)

Security Agreement between CytoDyn Inc. and Streeterville Capital, LLC dated November 10, 2020 (Filed With SEC on November 16, 2020)

Distribution and Supply Agreement between CytoDyn Inc. and American Regent, Inc. dated July 2, 2020 (Filed With SEC on August 18, 2020)

Description of the Registrants Capital Stock (Filed With SEC on August 14, 2020)

Distribution and Supply Agreement between CytoDyn Inc. and American Regent, Inc (Filed With SEC on August 14, 2020)

CytoDyn Inc. Amended and Restated 2012 Equity Incentive Plan (the 2012 Plan) (Filed With SEC on August 14, 2020)

Form of Stock Option Award Agreement for Executive Employees under the 2012 Plan (Filed With SEC on August 14, 2020)

Amended and Restated Employment Agreement by and between CytoDyn Inc. and Nitya G. Ray, Ph.D., dated June 15, 2020 (Filed With SEC on August 14, 2020)

General Release and Separation Agreement between CytoDyn Inc. and Craig S. Eastwood, dated April 24, 2020 (Filed With SEC on August 14, 2020)

Employment Agreement by and between CytoDyn Inc. and Arian Colachis, dated March 16, 2020 (Filed With SEC on August 14, 2020)

Employment Agreement by and between CytoDyn Inc. and Scott A. Kelly, M.D., dated April 10, 2020 (Filed With SEC on August 14, 2020)

Secured Convertible Promissory Note dated July 29, 2020 (Filed With SEC on July 31, 2020)

Securities Purchase Agreement between CytoDyn Inc. and Iliad Research and Trading, L.P. dated July 29, 2020 (Filed With SEC on July 31, 2020)

Security Agreement between CytoDyn Inc. and Iliad Research and Trading, L.P. dated July 29, 2020 (Filed With SEC on July 31, 2020)

Form of Restricted Stock Unit Agreement (Filed With SEC on June 19, 2020)

Form of Performance Stock Unit Agreement (Filed With SEC on June 19, 2020)

Form of Stock Option Agreement for Employees (Filed With SEC on June 19, 2020)

Amendment No. 5 to the 2012 Equity Incentive (Filed With SEC on June 19, 2020)

Second Amended and Restated Employment Agreement of CEO Nader Z. Pourhassan Ph.D (Filed With SEC on June 19, 2020)

Amended and Restated Employment Agreement CFO Michael D. Mulholland (Filed With SEC on June 19, 2020)

Form of Performance Share Award Agreement (Filed With SEC on April 9, 2020)

Secured Convertible Promissory Note, as amended (Filed With SEC on April 6, 2020)

Securities Purchase Agreement (Filed With SEC on April 6, 2020)

Security Agreement (Filed With SEC on April 6, 2020)

Form of Series D Warrant Agreement (Filed With SEC on February 3, 2020)

Form of Subscription Agreement (Filed With SEC on February 3, 2020)

Commercialization and License Agreement between CytoDyn Inc. and Vyera Pharmaceuticals, LLC, dated December 17, 2019 (Filed With SEC on January 9, 2020)

Supply Agreement between CytoDyn Inc. and Vyera Pharmaceuticals, LLC, dated December 17, 2019 (Filed With SEC on January 9, 2020)

Employment Agreement by and between CytoDyn Inc. and Craig S. Eastwood, dated December 6, 2019 (Filed With SEC on January 9, 2020)

Employment Agreement by and between CytoDyn Inc. and Maura Fleming, dated January 6, 2020 (Filed With SEC on January 9, 2020)

Form of Amendment to Executive Officer Employment Agreements (Filed With SEC on January 9, 2020)

Form of Warrant Agreement (Filed With SEC on December 27, 2019)

Form of Subscription Agreement (Filed With SEC on December 27, 2019)

Form of Warrant Exercise Agreement (Filed With SEC on December 27, 2019)

Form of Subscription Agreement (Filed With SEC on November 7, 2019)

Form of Series C Warrant Agreement (Filed With SEC on October 22, 2019)

Form of Subscription Agreement (Filed With SEC on October 22, 2019)

Form of Subscription Agreement (Filed With SEC on October 3, 2019)

Form of Subscription Agreement (Filed With SEC on September 19, 2019)

Form of Registered Direct Warrant Agreement (Filed With SEC on August 29, 2019)

Form of Registered Direct Subscription Agreement (Filed With SEC on August 29, 2019)

Form of Series C Subscription Agreement (Filed With SEC on August 29, 2019)

Placement Agent Agreement (Filed With SEC on August 29, 2019)

Description of the Registrants Capital Stock (Filed With SEC on August 14, 2019)

Master Services Agreement between CytoDyn Inc. and Samsung BioLogics Co., Ltd, dated April 1, 2019 (Filed With SEC on August 14, 2019)

Product Specific Agreement between CytoDyn Inc. and Samsung BioLogics Co., Ltd, dated April 1, 2019 (Filed With SEC on August 14, 2019)

Consulting Agreement, dated July 15, 2019, between CytoDyn Inc. and Scott A. Kelly, M.D (Filed With SEC on July 19, 2019)

Consulting Agreement, dated July 15, 2019, between CytoDyn Inc. and David F. Welch, Ph.D (Filed With SEC on July 19, 2019)

Form of Exercise Agreement (Filed With SEC on May 9, 2019)

Form of Warrant Agreement (Filed With SEC on April 5, 2019)

Form of Subscription Agreement (Filed With SEC on April 5, 2019)

Placement Agent Agreement (Filed With SEC on April 5, 2019)

Form of Series C Warrant Agreement (Filed With SEC on March 20, 2019)

Form of Subscription Agreement (Filed With SEC on March 20, 2019)

Form of Warrant Agreement (Filed With SEC on January 31, 2019)

Convertible Promissory Note Warrant Agreement (Filed With SEC on January 31, 2019)

Form of Subscription Agreement (Filed With SEC on January 31, 2019)

Placement Agent Agreement (Filed With SEC on January 31, 2019)

Convertible Promissory Note (Filed With SEC on January 30, 2019)

Securities Purchase Agreement (Filed With SEC on January 30, 2019)

Security Agreement (Filed With SEC on January 30, 2019)

Form of Convertible Promissory Note (Filed With SEC on January 3, 2019)

Form of Warrant to Purchase Common Stock (Filed With SEC on January 3, 2019)

Form of Subscription Agreement (Filed With SEC on January 3, 2019)

Employment Agreement by and between CytoDyn Inc. and Dr. Nitya G. Ray, dated December 22, 2018 (Filed With SEC on December 26, 2018)

Form of Indemnification Agreement (Filed With SEC on October 9, 2018)

Consulting Agreement between CytoDyn Inc. and Richard G. Pestell, M.D., Ph.D. dated as of August 27, 2018 (Filed With SEC on October 9, 2018)

Form of Investor Warrant (Filed With SEC on September 4, 2018)

Form of Subscription Agreement (Filed With SEC on September 4, 2018)

Acquisition Agreement by and among CytoDyn Inc., Point NewCo, Inc., Point Merger Sub, Inc., ProstaGene, LLC, and Dr. Richard Pestell, dated August 27, 2018 (Filed With SEC on August 28, 2018)

Form of Placement Agent Warrant (Private Offerings, as Amended) (Filed With SEC on July 27, 2018)

Form of Placement Agent Warrant (Registered Offerings, as Amended) (Filed With SEC on July 27, 2018)

Convertible Promissory Note (Filed With SEC on June 27, 2018)

Securities Purchase Agreement (Filed With SEC on June 27, 2018)

Form of Warrant Agreement (Filed With SEC on May 22, 2018)

Form of Subscription Agreement (Filed With SEC on May 22, 2018)

Placement Agent Agreement (Filed With SEC on May 22, 2018)

Form of Amendment to Placement Agent Warrants (Filed With SEC on April 9, 2018)

Form of Warrant Agreement (Filed With SEC on January 31, 2018)

Form of Subscription Agreement (Filed With SEC on January 31, 2018)

Form of Warrant Agreement (Filed With SEC on January 23, 2018)

Form of Subscription Agreement (Filed With SEC on January 23, 2018)

Form of Placement Agent Agreement (Filed With SEC on January 23, 2018)

Form of Placement Agent Warrant (September/October 2017 Offering) (Filed With SEC on January 8, 2018)

Form of Waiver and Subscription Agreement (Filed With SEC on December 6, 2017)

Form of Investor Warrant (Filed With SEC on November 8, 2017)

Form of Subscription Agreement (Filed With SEC on November 8, 2017)

Form of Warrant Agreement (Filed With SEC on October 11, 2017)

Form of Subscription Agreement (Filed With SEC on October 11, 2017)

Form of Warrant Agreement (Filed With SEC on September 8, 2017)

Form of Subscription Agreement (Filed With SEC on September 8, 2017)

Form of Securities Purchase Agreement (Filed With SEC on September 8, 2017)

Form of Placement Agent Agreement (Filed With SEC on September 8, 2017)

COMMON STOCK PURCHASE WARRANT CYTODYN INC. (Filed With SEC on July 20, 2017)

PURCHASE WARRANT Issued to: [ ] Exercisable to Purchase [ ] Shares of Common Stock of CYTODYN INC. Warrant No. P - [ ] Void after [ ], 20[ ] (Filed With SEC on July 20, 2017)

CYTODYN INC. 2012 EQUITYINCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on July 20, 2017)

Form of Convertible Promissory Note (Filed With SEC on June 22, 2017)

Form of Warrant to Purchase Common Stock (Filed With SEC on June 22, 2017)

Form of Placement Agent Warrant (Filed With SEC on June 22, 2017)

Form of Consultant Warrant (Filed With SEC on June 22, 2017)

Form of Subscription Agreement (Filed With SEC on June 22, 2017)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on June 2, 2017)

Warrant to Purchase Shares of Common Stock As HereinDescribed , 2017 WARRANT TO PURCHASE COMMON STOCK OF CYTODYN INC. (Filed With SEC on June 2, 2017)

SUBSCRIPTION AGREEMENT (Filed With SEC on June 2, 2017)

DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on April 13, 2017)

WORK STATEMENT NO. 01 (Filed With SEC on April 13, 2017)

COMMON STOCK PURCHASE WARRANT CYTODYN INC. (Filed With SEC on February 28, 2017)

SUBSCRIPTION AGREEMENT (Filed With SEC on February 28, 2017)

AMENDMENTS TO THE CYTODYN INC. 2012 EQUITY INCENTIVE PLAN Dated: February 12, 2017 (Filed With SEC on February 13, 2017)

COMMON STOCK PURCHASE WARRANT CYTODYN INC. (Filed With SEC on January 31, 2017)

SUBSCRIPTION AGREEMENT (Filed With SEC on January 31, 2017)

PLACEMENT AGENT AGREEMENT January 11, 2017 (Filed With SEC on January 31, 2017)

FIRST AMENDMENT TO PLACEMENTAGENT AGREEMENT January 30, 2017 (Filed With SEC on January 31, 2017)

COMMON STOCK PURCHASE WARRANT CYTODYN INC. (Filed With SEC on December 12, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 12, 2016)

SUBSCRIPTION AGREEMENT (Filed With SEC on October 12, 2016)

COMMON STOCK PURCHASE WARRANT CYTODYN INC. (Filed With SEC on September 12, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 12, 2016)

SUBSCRIPTION AGREEMENT (Filed With SEC on May 11, 2016)

WARRANT TO PURCHASE COMMON STOCK OF CYTODYN INC. [ ], 20[ ] (Filed With SEC on February 3, 2016)

SUBSCRIPTION AGREEMENT (Filed With SEC on February 3, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 3, 2016)

CYTODYN INC. AMENDMENTNO. 2 TO CONSULTING AGREEMENT (Filed With SEC on January 22, 2016)

CYTODYN INC. SUMMARY OFNON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM EFFECTIVE JUNE 1, 2015 (Filed With SEC on October 9, 2015)

Warrant to Purchase Shares of Common Stock As Herein Described , 2015 WARRANT TO PURCHASE COMMON STOCK OF CYTODYN INC. (Filed With SEC on September 11, 2015)

PURCHASE WARRANT Issued to: Exercisable to Purchase Shares ofCommon Stock of CYTODYNINC. Warrant No. P - Void after , 2020 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE... (Filed With SEC on September 11, 2015)

SUBSCRIPTION AGREEMENT (Filed With SEC on September 11, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 11, 2015)

WARRANT TO PURCHASE COMMON STOCK OF CYTODYN INC. [ ], 2013 (Filed With SEC on September 2, 2015)

Warrant to Purchase Shares of Common Stock As Herein Described , 2015 WARRANT TO PURCHASE COMMON STOCK OF CYTODYN INC. (Filed With SEC on September 2, 2015)

LICENCE AGREEMENT between LONZA SALES AG and CYTODYN INC. INDEX (Filed With SEC on August 19, 2015)

AMENDMENT TO CONVERTIBLE PROMISSORY NOTE (Filed With SEC on July 10, 2015)

CYTODYN INC. AMENDMENTTO CONSULTING AGREEMENT (Filed With SEC on July 10, 2015)

DEBT CONVERSION AND TERMINATION AGREEMENT (Filed With SEC on June 25, 2015)

Form of Inducement Warrant PURCHASE WARRANT Issued to: Alpha Venture Capital Partners, LP Exercisable to Purchase 1,000,000 Shares of Common Stock of CYTODYN INC. Warrant No. A-80... (Filed With SEC on June 25, 2015)

PURCHASE WARRANT Issued to: [ ] Exercisable to Purchase [ ] Shares of Common Stock of CYTODYN INC. Warrant No. A [ ] Void after May 15, 2020 THIS WARRANT HAS NOT BEEN REGISTERED... (Filed With SEC on May 18, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on May 5, 2015)

SUBSCRIPTION AGREEMENT (Filed With SEC on May 5, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 11, 2015)

Warrant to Purchase Shares of Common Stock As HereinDescribed February 6, 2015 WARRANT TO PURCHASE COMMON STOCK OF CYTODYN INC. (Filed With SEC on February 11, 2015)

CYTODYN INC. SUBSCRIPTION AND INVESTOR RIGHTS AGREEMENT FOR CONVERTIBLE PROMISSORY NOTES AND WARRANTS (Filed With SEC on February 11, 2015)

Letter of Understanding (Filed With SEC on February 11, 2015)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on January 7, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on January 7, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 10, 2014)

Warrant to Purchase Shares of Common Stock As HereinDescribed September 26, 2014 WARRANT TO PURCHASE COMMON STOCK OF CYTODYN INC. (Filed With SEC on October 10, 2014)

CYTODYN INC. SUBSCRIPTION AND INVESTOR RIGHTS AGREEMENT FOR CONVERTIBLE PROMISSORY NOTES AND WARRANTS (Filed With SEC on October 10, 2014)

Alpha Venture Capital Management, LLC Post Office Box 2477 Lakeland,Florida, 33806, USA September 25, 2014 (Filed With SEC on October 10, 2014)

CYTODYN INC. SUMMARYOF NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM EFFECTIVE JUNE 1, 2014 (Filed With SEC on October 10, 2014)

CYTODYN INC. CONSULTINGAGREEMENT (Filed With SEC on July 10, 2014)

CLINICAL TRIAL AGREEMENT (Filed With SEC on April 11, 2014)

AMENDMENT TO CLINICAL RESEARCH COLLABORATION AGREEMENT (Filed With SEC on April 11, 2014)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 15, 2013)

WARRANT TO PURCHASE COMMON STOCK OF CYTODYN INC. , 2013 (Filed With SEC on November 15, 2013)

Form of CytoDyn Inc. PURCHASE WARRANT Issued to: PAULSON INVESTMENT COMPANY, INC. (or its designees) Exercisable to Purchase [ ] Shares of Common Stock Of CYTODYN INC. Warrant No.... (Filed With SEC on November 15, 2013)

CYTODYN INC. 2004STOCK INCENTIVE PLAN FORM OF STOCK OPTION AWARD FOR EMPLOYEES (Filed With SEC on August 29, 2013)

CYTODYN INC. 2004 STOCK INCENTIVE PLAN FORM OF STOCK OPTION AWARD FOR NON-EMPLOYEE DIRECTORS Grant Date , 20 (Filed With SEC on August 29, 2013)

CYTODYN INC. 2012 EQUITY INCENTIVE PLAN FORM OF STOCK OPTION AWARD AGREEMENT (FOR EMPLOYEES) (Filed With SEC on August 29, 2013)

CYTODYN INC. 2012 EQUITY INCENTIVE PLAN FORM OF STOCK OPTION AWARD AGREEMENT (FOR NON-EMPLOYEE DIRECTORS) (Filed With SEC on August 29, 2013)

THIS STOCK OPTION AND THE COMMON STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE SECURITIES LAWS. NEITHER THIS... (Filed With SEC on August 29, 2013)

CYTODYN INC. SUMMARY OF NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM EFFECTIVE JUNE 1, 2013 (Filed With SEC on August 29, 2013)

EMPLOYMENT AND NON-COMPETE AGREEMENT (Filed With SEC on August 29, 2013)

PROMISSORY NOTE (Filed With SEC on August 29, 2013)

FORM OF COMMON STOCK WARRANT AGREEMENT (Filed With SEC on August 29, 2013)

CONSULTING AGREEMENT (Filed With SEC on August 29, 2013)

DEVELOPMENT AND LICENSE AGREEMENT between PROTEIN DESIGN LABS, INC. and PROGENICS PHARMACEUTICALS, INC. (Filed With SEC on August 29, 2013)

CLINICAL RESEARCH COLLABORATION AGREEMENT (Filed With SEC on August 29, 2013)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on June 10, 2013)

FORM OF CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 12, 2013)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 12, 2013)

FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on January 14, 2013)

CYTODYN INC. 2012 EQUITY INCENTIVE PLAN TABLE OF CONTENTS (Filed With SEC on December 18, 2012)

CYTODYN INC. NON-EMPLOYEE BOARD OF DIRECTORS COMPENSATION EFFECTIVE JUNE 1, 2012 (Filed With SEC on October 9, 2012)

ASSET PURCHASE AGREEMENT (Filed With SEC on July 30, 2012)

TRANSITION AGREEMENT (Filed With SEC on July 25, 2012)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 20, 2012)

PURCHASE AND SALE AGREEMENT (Filed With SEC on April 11, 2012)

RESEARCH FUNDING AND OPTION AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and Cytodyn Inc, a Colorado corporation 1... (Filed With SEC on November 16, 2011)

AMENDMENT NUMBER FIVE TO CLINICAL TRIAL AGREEMENT (Filed With SEC on November 3, 2011)

AMENDMENT NUMBER FOUR TO CLINICAL TRIAL AGREEMENT (Filed With SEC on October 7, 2011)

CONSULTING AGREEMENT (Filed With SEC on July 18, 2011)

AMENDMENT NUMBER FIVE TO CLINICAL TRIAL AGREEMENT (Filed With SEC on May 24, 2011)

Category

Industry

Companies

Contracts

CytoDyn Inc. Contracts & Agreements